blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3019164

EP3019164 - USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF PENETRATING HEAD INJURY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.06.2021
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  17.07.2020
FormerGrant of patent is intended
Status updated on  23.02.2020
FormerExamination is in progress
Status updated on  27.04.2018
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
Goldstein, Glenn A.
157 East 57th Street Suite 5F
New York, NY 10022 / US
[2016/20]
Inventor(s)01 / GOLDSTEIN, Glenn A.
157 East 57th Street Suite 5F
New York, NY 10022 / US
 [2016/20]
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[2020/34]
Former [2016/20]Høiberg A/S
St. Kongensgade 59 A
1264 Copenhagen K / DK
Application number, filing date14823046.910.07.2014
[2016/20]
WO2014US46166
Priority number, dateUS201361844653P10.07.2013         Original published format: US 201361844653 P
US201361858871P26.07.2013         Original published format: US 201361858871 P
US201361891034P15.10.2013         Original published format: US 201361891034 P
[2016/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2015006569
Date:15.01.2015
Language:EN
[2015/02]
Type: A2 Application without search report 
No.:EP3019164
Date:18.05.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 15.01.2015 takes the place of the publication of the European patent application.
[2016/20]
Type: B1 Patent specification 
No.:EP3019164
Date:19.08.2020
Language:EN
[2020/34]
Search report(s)International search report - published on:KR15.01.2015
(Supplementary) European search report - dispatched on:EP10.02.2017
ClassificationIPC:A61K31/16, A61P25/00, A61P29/00
[2017/11]
CPC:
A61K31/16 (EP,US); A61P17/02 (EP); A61P25/00 (EP);
A61P29/00 (EP); A61P43/00 (EP); A61P9/00 (EP);
A61P9/10 (EP) (-)
Former IPC [2016/20]A61K31/195, A61K31/19, A61P25/00, A61P29/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/20]
Extension statesBA10.02.2016
ME10.02.2016
TitleGerman:VERWENDUNG VON N-ACETYLCYSTEINAMID IN DER BEHANDLUNG VON PENTRIERENDER KOPFLÄSION[2016/20]
English:USE OF N-ACETYLCYSTEINE AMIDE IN THE TREATMENT OF PENETRATING HEAD INJURY[2016/20]
French:EMPLOI DE N-ACÉTYLCYSTÉINE AMIDE DANS LE TRAITEMENT DE LÉSIONS PROFONDES À LA TÊTE[2016/20]
Entry into regional phase10.02.2016National basic fee paid 
10.02.2016Search fee paid 
10.02.2016Designation fee(s) paid 
10.02.2016Examination fee paid 
Examination procedure10.02.2016Examination requested  [2016/20]
11.09.2017Amendment by applicant (claims and/or description)
26.04.2018Despatch of a communication from the examining division (Time limit: M06)
31.10.2018Reply to a communication from the examining division
04.02.2019Despatch of a communication from the examining division (Time limit: M02)
07.03.2019Reply to a communication from the examining division
05.07.2019Despatch of a communication from the examining division (Time limit: M04)
15.11.2019Reply to a communication from the examining division
24.02.2020Communication of intention to grant the patent
03.07.2020Fee for grant paid
03.07.2020Fee for publishing/printing paid
03.07.2020Receipt of the translation of the claim(s)
Opposition(s)20.05.2021No opposition filed within time limit [2021/30]
Fees paidRenewal fee
01.07.2016Renewal fee patent year 03
25.07.2017Renewal fee patent year 04
11.07.2018Renewal fee patent year 05
30.07.2019Renewal fee patent year 06
14.07.2020Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.07.2014
AL19.08.2020
AT19.08.2020
CY19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
ES19.08.2020
FI19.08.2020
HR19.08.2020
IT19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
MK19.08.2020
MT19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
[2024/41]
Former [2024/22]HU10.07.2014
AL19.08.2020
AT19.08.2020
CY19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
ES19.08.2020
FI19.08.2020
HR19.08.2020
IT19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
MK19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2023/30]HU10.07.2014
AL19.08.2020
AT19.08.2020
CY19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
ES19.08.2020
FI19.08.2020
HR19.08.2020
IT19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2023/29]HU10.07.2014
AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
ES19.08.2020
FI19.08.2020
HR19.08.2020
IT19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2022/18]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
ES19.08.2020
FI19.08.2020
HR19.08.2020
IT19.08.2020
LT19.08.2020
LV19.08.2020
MC19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/36]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
ES19.08.2020
FI19.08.2020
HR19.08.2020
IT19.08.2020
LT19.08.2020
LV19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SI19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/34]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
ES19.08.2020
FI19.08.2020
HR19.08.2020
IT19.08.2020
LT19.08.2020
LV19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/28]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
ES19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SK19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/25]AL19.08.2020
AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
ES19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/23]AT19.08.2020
CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
SM19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/22]CZ19.08.2020
DK19.08.2020
EE19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
NL19.08.2020
PL19.08.2020
RO19.08.2020
RS19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/21]DK19.08.2020
FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
NL19.08.2020
PL19.08.2020
RS19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/12]FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
NL19.08.2020
PL19.08.2020
RS19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/10]FI19.08.2020
HR19.08.2020
LT19.08.2020
LV19.08.2020
PL19.08.2020
RS19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
IS19.12.2020
PT21.12.2020
Former [2021/09]FI19.08.2020
LT19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
GR20.11.2020
PT21.12.2020
Former [2021/08]FI19.08.2020
LT19.08.2020
SE19.08.2020
BG19.11.2020
NO19.11.2020
PT21.12.2020
Former [2021/07]FI19.08.2020
LT19.08.2020
NO19.11.2020
Documents cited:Search[XD]WO2006116353  (GOLDSTEIN GLENN [US]) [XD] 1-15* page 48, line 30; claim - *;
 [X]WO2011044230  (GOLDSTEIN GLENN A [US]) [X] 1-15 * page 59, line 9; examples 15, 16; claim 7 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.